Trademark Details For MY PROSTATE CANCER ROADMAP (Serial Number 88020194)

  •  Home
  •  Print
MY PROSTATE CANCER ROADMAP
10
73
36
0
Serial Number  United States - USPTO 88020194
Registration Number 5685071
Mark
MY PROSTATE CANCER ROADMAP
Filing Date Jun-29-2018
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
Attorney Name
TTAB
0
Action Tags
  




044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active

First Use: Sep-01-2010

First Use in Commerce: Sep-01-2010





Correspondences

NameDanielle Rivera JOHNSON & JOHNSON
AddressONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933 United States

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-03-2018NEW APPLICATION ENTERED   NWAPI
Jul-05-2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-26-2018ASSIGNED TO EXAMINER   DOCKD
Sep-29-2018
NON-FINAL ACTION WRITTEN
  
CNRTR
Sep-29-2018NON-FINAL ACTION E-MAILED   GNRTF
Sep-29-2018
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Oct-15-2018TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Oct-15-2018CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Oct-16-2018TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Oct-17-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Oct-31-2018ASSIGNED TO LIE   ALIEA
Nov-21-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-11-2018PUBLISHED FOR OPPOSITION   PUBOA
Dec-11-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Feb-26-2019REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-24-2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Nov-24-2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Nov-24-2021TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Feb-26-2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Jan-15-2025TEAS SECTION 8 RECEIVED   ES8RI
May-26-2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
May-27-2025REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
May-27-2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E